F. Andermann

1.4k total citations
19 papers, 909 citations indexed

About

F. Andermann is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Clinical Biochemistry. According to data from OpenAlex, F. Andermann has authored 19 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Clinical Biochemistry. Recurrent topics in F. Andermann's work include Epilepsy research and treatment (9 papers), Metabolism and Genetic Disorders (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). F. Andermann is often cited by papers focused on Epilepsy research and treatment (9 papers), Metabolism and Genetic Disorders (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). F. Andermann collaborates with scholars based in Canada, Australia and Italy. F. Andermann's co-authors include J. Preston Robb, Allan L. Sherwin, E. Andermann, Suzan Dyve, Jakob Reith, Paul Cumming, Chawki Benkelfat, Hiroto Kuwabara, Mirko Dikšić and Samuel F. Berkovic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, NeuroImage and Neurology.

In The Last Decade

F. Andermann

18 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Andermann Canada	12	480	425	275	171	158	19	909
Michael Gruenthal United States	17	331 0.7×	492 1.2×	148 0.5×	288 1.7×	127 0.8×	29	1.2k
Agnete Mouritzen Dam Denmark	13	605 1.3×	695 1.6×	250 0.9×	234 1.4×	240 1.5×	23	1.3k
Cheolsu Shin United States	18	632 1.3×	719 1.7×	267 1.0×	247 1.4×	278 1.8×	33	1.4k
Diosely C. Silveira United States	18	688 1.4×	887 2.1×	558 2.0×	240 1.4×	337 2.1×	39	1.5k
Delia Mendoza United States	13	425 0.9×	968 2.3×	142 0.5×	363 2.1×	152 1.0×	14	1.1k
Y Løyning Norway	13	722 1.5×	582 1.4×	611 2.2×	196 1.1×	236 1.5×	21	1.3k
Chong L. Lee United States	15	293 0.6×	581 1.4×	129 0.5×	207 1.2×	191 1.2×	19	814
Tuuli Salmenperä Finland	20	886 1.8×	720 1.7×	429 1.6×	140 0.8×	341 2.2×	26	1.3k
Yohtaro Numachi Japan	15	309 0.6×	439 1.0×	74 0.3×	269 1.6×	222 1.4×	33	876
S. da Costa Araújo United Kingdom	7	276 0.6×	343 0.8×	126 0.5×	172 1.0×	73 0.5×	10	773

Countries citing papers authored by F. Andermann

Since Specialization

Citations

This map shows the geographic impact of F. Andermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Andermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Andermann more than expected).

Fields of papers citing papers by F. Andermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Andermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Andermann. The network helps show where F. Andermann may publish in the future.

Co-authorship network of co-authors of F. Andermann

This figure shows the co-authorship network connecting the top 25 collaborators of F. Andermann. A scholar is included among the top collaborators of F. Andermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Andermann. F. Andermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Andermann, F., et al.. (2019). Epilepsia Open ‐ November 2019 ‐ Announcements. Epilepsia Open. 4(4). 624–626. 1 indexed citations

Camfield, P. R. & F. Andermann. (2006). SUCCESSFUL TREATMENT OF TWO CASES OF ALTERNATING HEMIPLEGIA WITH ACETAZOLAMIDE. Neuropediatrics. 37(S 1). 4 indexed citations

Andermann, F.. (2000). Migraine and the benign partial epilepsies of childhood: evidence for an association.. PubMed. 2 Suppl 1. S37–9. 19 indexed citations

Bittar, Richard G., Alain Ptito, Serge O. Dumoulin, F. Andermann, & David C. Reutens. (1998). Demonstration of large-scale reorganization of the visual cortex with functional magnetic resonance imaging (fMRI). NeuroImage. 7(4). S490–S490. 2 indexed citations

Bittar, Richard G., André Olivier, Abbas F. Sadikot, et al.. (1998). Presurgical planning with fMRI: Cross-validation with PET. NeuroImage. 7(4). S64–S64. 1 indexed citations

Shevell, Michael, et al.. (1998). Treatment of absence status in the Lennox-Gastaut syndrome with propofol. Neurology. 51(1). 315–316. 6 indexed citations

Andermann, F., et al.. (1998). Epilepsy induced by thinking and spatial tasks.. PubMed. 75. 263–72. 17 indexed citations

Dobyns, William B., E. Andermann, F. Andermann, et al.. (1996). X-linked malformations of neuronal migration. Neurology. 47(2). 331–339. 171 indexed citations

O’Gorman, Augustin M., et al.. (1995). Lesionectomy of MRI Detected Lesions in Children with Epilepsy. Pediatric Neurosurgery. 22(4). 167–173. 33 indexed citations

10.

Reith, Jakob, Chawki Benkelfat, Allan L. Sherwin, et al.. (1994). Elevated dopa decarboxylase activity in living brain of patients with psychosis.. Proceedings of the National Academy of Sciences. 91(24). 11651–11654. 249 indexed citations

11.

Dubeau, François, Allan L. Sherwin, André Olivier, et al.. (1992). Excitatory Amino Acids Modulate Phosphoinositide Signal Transduction in Human Epileptic Neocortex. Epilepsia. 33(2). 255–262. 15 indexed citations

12.

Berkovic, Samuel F., N. So, & F. Andermann. (1991). Progressive myoclonus epilepsies: clinical and neurophysiological diagnosis.. PubMed. 8(3). 261–74. 49 indexed citations

13.

Berkovic, Samuel F., et al.. (1989). Valproate prevents the recurrence of absence status. Neurology. 39(10). 1294–1294. 35 indexed citations

14.

Sherwin, Allan L., Yves Robitaille, Felipe Quesney, et al.. (1988). Excitatory amino acids are elevated in human epileptic cerebral cortex. Neurology. 38(6). 920–920. 109 indexed citations

15.

Andermann, F., et al.. (1987). Malignant migraine: the syndrome of prolonged classical migraine, epilepsia partialis continua, and repeated strokes; a clinically characteristic disorder probably due to mitochondrial encephalopathy.. PubMed. 1(4). 481–6. 12 indexed citations

16.

Sherwin, Allan L., William Feindel, F. Andermann, et al.. (1986). Stability of alpha-1 adrenoceptors in surgically excised human brain. Life Sciences. 39(11). 953–958. 5 indexed citations

17.

Keene, D. L., et al.. (1981). Anoxic Tonic Seizures Due to Asthma; A Serious Complication in Adults. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 8(2). 177–179. 2 indexed citations

18.

Gelder, N. M. van, Allan L. Sherwin, Chana A. Sacks, & F. Andermann. (1975). Biochemical observations following administration of taurine to patients with epilepsy. Brain Research. 94(2). 297–306. 53 indexed citations

19.

Andermann, F. & J. Preston Robb. (1972). Absence Status A Reappraisal following Review of Thirty‐eight Patients. Epilepsia. 13(1). 177–187. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact